title: The influence of continuous glucose monitoring of high-risk neonate on guiding perinatal complications and one-year follow-up results.
abstract: OBJECTIVE
  To investigate the value of micro blood glucose monitoring of high risk neonate on guiding perinatal complications and one-year follow-up results.
  
  
  METHODS
  A total of 268 cases that were diagnosed as high-risk neonates by our Obstetrics Department from June 2010 to June 2014 were enrolled. After measuring their micro blood glucose instantly, 6h, 12h, 24h, 1d, 2d and 3d after delivery, divided them into two groups: hypoglycemic group (n = 54) and normal group (n = 214). And then the differences of perinatal complications and their one-year follow-up results were compared.
  
  
  RESULTS
  The occurrence of perinatal complications in hypoglycemic group was significantly higher than that in normal group (p < 0.05); the faster the hypoglycemia occurred, the longer the duration was, and the severer the complications were. Hypoglycemia often occurred prior to the complications. The mental development index (MDI) and the physical development index (PDI) of hypoglycemic group were significantly lower than those in the normal group and differences were statistically significant (p < 0.05).
  
  
  CONCLUSIONS
  Continuous blood glucose monitoring of high-risk neonate was of great significance in guiding perinatal complications at one-year follow-up.
authors.affiliation: Neonatal Department of Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu, China. idw5360@163.com.
authors.forename: P-W
authors.initials: PW
authors.lastname: Shang
authors.forename: G-Z
authors.initials: GZ
authors.lastname: Lu
authors.forename: X
authors.initials: X
authors.lastname: Sun
authors.forename: Z-M
authors.initials: ZM
authors.lastname: Bian
authors.forename: Z-Y
authors.initials: ZY
authors.lastname: Shang
authors.forename: J
authors.initials: J
authors.lastname: Li
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D002657:Child Development / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007003:Hypoglycemia / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D007231:Infant, Newborn; D008297:Male; D008991:Monitoring, Physiologic; D012306:Risk
chemical_list: D001786:Blood Glucose